Middlebrook Pharma adds 271 reps

Share this article:
Westlake, Texas-based MiddleBrook Pharmaceuticals, Inc. has completed the hiring of its 271-person nationwide field sales force. The 271 territory managers comprising MiddleBrook's field sales force will begin educating healthcare professionals on the benefits of Moxatag (extended-release amoxicillin) tablets, 775 mg—a once-daily amoxicillin that was approved by the FDA on Jan. 23, 2009.

According to Middlebrook officials, MiddleBrook's territories have been structured to maximize the 271-person field sales force's ability to detail healthcare professionals nationwide, including pharmacists. The field force's efforts will be supported by a print media campaign targeted at healthcare professionals. 

John Thievon, president and CEO of MiddleBrook  said, “MiddleBrook's field sales force will be talking to physicians and pharmacists across the country about the benefits of Moxatag, patient convenience, improved compliance and a lower overall daily dose.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.